LAS VEGAS, Feb. 22, 2011 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCQB:SKVI) announced that the Canadian Patent Office has issued a Notice of Allowance for the comprehensive technology patent for Skinvisible's Invisicare polymer delivery system. Invisicare is the core technology in Skinvisible's portfolio of products which consists of thirty-six formulated topical products including prescription, over-the-counter and cosmetic formulations. Invisicare enhances the delivery of topical products with water insoluble actives as well as certain cationic actives by controlling the release of these actives as well as binding the products to the skin for an extended duration.
